Results of a Study Examining the Use of OnabotulinumtoxinA in Pediatric Patients With Overactive Bladder
Hoebeke P, Hittelman A, Jenkins B, Geib T, Titanji W, Bogaert G. Results of a Study Examining the Use of OnabotulinumtoxinA in Pediatric Patients With Overactive Bladder. Journal Of Pediatric Urology 2024 PMID: 38906707, DOI: 10.1016/j.jpurol.2024.04.019.Peer-Reviewed Original ResearchTreatment-emergent adverse eventsOveractive bladderPediatric patientsUrinary retentionUI episodesPrimary endpointTreatment of overactive bladderResponse rateUrinary incontinence (UIFrequency of UI episodesMultiple-dose studyNumerically greater reductionsLack of approved treatmentsTreatment cycles 1Urinary tract infectionBaseline to weekTreat overactive bladderTreatment response ratesTreatment cycle 2Dose armAnticholinergic therapyDouble-blindPlacebo armOnabotulinumtoxinA injectionsTract infections